tarasovcode
Business1 min readSiliconANGLE AI

AI drug development startup Pathos AI closes $237M investment

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. …

Save
Share:VKTelegramWhatsApp
AI drug development startup Pathos AI closes $237M investment
Illustration: Tarasov Code

In brief

  • What: AI drug development startup Pathos AI closes $237M investment
  • When: October 23, 2026 at 23:02
  • Source: SiliconANGLE AI (media)
  • Topic: Business

#Funding#Business

Prepared by Ilya Tarasov’s Tarasov Code newsroom based on a report by SiliconANGLE AI.

Read next

OpenAI · October 23, 2026Rapidly scaling online storage to serve over 1 billion ChatGPT users (Part II)SiliconANGLE AI · October 23, 2026Report: OpenAI closing on $30B ‘bridge’ funding round to tide it over before IPOTechCrunch AI · October 23, 2026OpenAI working on new $30B raise at $1.25T valuation ahead of IPOTechCrunch AI · October 22, 2026Nirva raises $33M for a pendant that only listens to you